Maitri Kalra

680 total citations · 1 hit paper
22 papers, 164 citations indexed

About

Maitri Kalra is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Maitri Kalra has authored 22 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Maitri Kalra's work include Testicular diseases and treatments (6 papers), Single-cell and spatial transcriptomics (2 papers) and Advanced Chemical Sensor Technologies (2 papers). Maitri Kalra is often cited by papers focused on Testicular diseases and treatments (6 papers), Single-cell and spatial transcriptomics (2 papers) and Advanced Chemical Sensor Technologies (2 papers). Maitri Kalra collaborates with scholars based in United States, Slovakia and Denmark. Maitri Kalra's co-authors include Harikrishna Nakshatri, Nasser H. Hanna, Lawrence H. Einhorn, Manjushree Anjanappa, Poornima Bhat‐Nakshatri, Brijesh Kumar, Yunlong Liu, Mayuri Prasad, Sheng Liu and Xi Rao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Maitri Kalra

19 papers receiving 164 citations

Hit Papers

Trastuzumab deruxtecan in patients with solid tumours har... 2024 2026 2025 2024 10 20 30 40

Peers

Maitri Kalra
Michele Ly United States
Atulya Aman Khosla United States
Kerstie Johnson United Kingdom
Elodie Noël United Kingdom
Maitri Kalra
Citations per year, relative to Maitri Kalra Maitri Kalra (= 1×) peers Ray Manneh Kopp

Countries citing papers authored by Maitri Kalra

Since Specialization
Citations

This map shows the geographic impact of Maitri Kalra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maitri Kalra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maitri Kalra more than expected).

Fields of papers citing papers by Maitri Kalra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maitri Kalra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maitri Kalra. The network helps show where Maitri Kalra may publish in the future.

Co-authorship network of co-authors of Maitri Kalra

This figure shows the co-authorship network connecting the top 25 collaborators of Maitri Kalra. A scholar is included among the top collaborators of Maitri Kalra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maitri Kalra. Maitri Kalra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bob T., Funda Meric‐Bernstam, Aditya Bardia, et al.. (2024). Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study. The Lancet Oncology. 25(6). 707–719. 43 indexed citations breakdown →
2.
Kalra, Maitri, et al.. (2023). Platelet Delta (δ)-Storage Pool Deficiency: A Case Series and Review of the Literature. SHILAP Revista de lepidopterología. 15(3). 405–410. 3 indexed citations
3.
Mamdani, Hirva, Ryan D. Gentzler, Maitri Kalra, et al.. (2023). A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer. 24(4). 347–352. 2 indexed citations
4.
Wang, Luqi, Shengzhi Liu, Maitri Kalra, et al.. (2022). Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time. Molecules. 27(13). 4277–4277. 5 indexed citations
5.
Kalra, Maitri, et al.. (2022). Familial Hypertrophic Cardiomyopathy With Fasciculoventricular Accessory Pathway. JACC Case Reports. 4(4). 198–204. 1 indexed citations
6.
Kalra, Maitri, Yan Tong, David Jones, et al.. (2021). Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer. npj Breast Cancer. 7(1). 29–29. 20 indexed citations
7.
Wang, Luqi, Shengzhi Liu, Amanda P. Siegel, et al.. (2021). Tracking the Progression of Triple Negative Mammary Tumors over Time by Chemometric Analysis of Urinary Volatile Organic Compounds. Cancers. 13(6). 1462–1462. 13 indexed citations
8.
Khanal, Nabin, Maitri Kalra, Thomas Miller, et al.. (2019). The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy. Supportive Care in Cancer. 28(7). 3165–3170. 4 indexed citations
9.
Kalra, Maitri, Nabil Adra, Nasser H. Hanna, Rafat Abonour, & Lawrence H. Einhorn. (2019). High‐dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases. Cancer. 126(6). 1202–1207. 11 indexed citations
10.
Kumar, Brijesh, Mayuri Prasad, Poornima Bhat‐Nakshatri, et al.. (2018). Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade. Cancer Research. 78(17). 5107–5123. 38 indexed citations
11.
Kumar, Brijesh, Mayuri Prasad, Poornima Bhat‐Nakshatri, et al.. (2018). Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade. PMC. 1 indexed citations
12.
Khanal, Nabin, Maitri Kalra, Nasser H. Hanna, et al.. (2018). Hypogonadism and effects on quality of life in previously treated germ cell tumor survivors: A single-centre, non-randomized, prospective observational study.. Journal of Clinical Oncology. 36(15_suppl). 10079–10079.
13.
Kalra, Maitri, Meghan Karuturi, Rachel C. Jankowitz, et al.. (2018). Dissemination of breast cancer knowledge and expertise from NCI-CCC tumor boards with community oncologists.. Journal of Clinical Oncology. 36(15_suppl). e18575–e18575.
14.
Cary, Clint, Maitri Kalra, Alvaro G. Menendez, et al.. (2018). A pilot study to assess the accuracy of “intuition” in analyzing post chemotherapy (chemo) residual retroperitoneal (RP) masses in patients (pts) with non seminomatous germ cell tumor (NSCGCT).. Journal of Clinical Oncology. 36(15_suppl). e16535–e16535. 1 indexed citations
15.
Chovanec, Michal, Maitri Kalra, Noah M. Hahn, et al.. (2017). Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review. Targeted Oncology. 13(1). 49–60. 8 indexed citations
16.
Kalra, Maitri & Harikrishna Nakshatri. (2017). Will PI3K-targeted therapies for cancer become a reality?. Translational Cancer Research. 6(S2). S371–S375. 1 indexed citations
18.
Adra, Nabil, Maitri Kalra, Sandra K. Althouse, et al.. (2016). Survival outcomes of patients with metastatic germ cell tumor (mGCT) treated from 1998 to 2012: The Indiana University (IU) experience.. Journal of Clinical Oncology. 34(2_suppl). 491–491. 5 indexed citations
19.
Kalra, Maitri, et al.. (2014). Abdominal Imaging is Insensitive in Diagnosis of Ipilimumab-Induced Colitis. The American Journal of Gastroenterology. 109. S428–S428. 1 indexed citations
20.
Kalra, Maitri. (2008). MDCT : From Protocols to Practice. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026